Tourettes syndrome, a disease consisting mainly of tics starting in childhood can be very debilitating. Wallstreet Journal health blog has an interview with the researcher
What sets the latest trial apart is that it’s “the first and only study that’s executed as a prospective, randomized, double-blind trial,” for Tourette’s patients, lead author, Robert Maciunas, a neurosurgeon at Case Western Reserve University School of Medicine tells the Health Blog. “We found dramatic, life-changing results.” The results appear in this month’s issue of the Journal of Neurosurgery. The study was done by University Hospitals Case Medical Center.
Related posts on this blog: